These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 23138834

  • 1. The pharmacological management of post-stroke muscle spasticity.
    Bakheit AM.
    Drugs Aging; 2012 Dec; 29(12):941-7. PubMed ID: 23138834
    [Abstract] [Full Text] [Related]

  • 2. Hypertonia.
    Evans SH, Cameron MW, Burton JM.
    Curr Probl Pediatr Adolesc Health Care; 2017 Jul; 47(7):161-166. PubMed ID: 28716516
    [Abstract] [Full Text] [Related]

  • 3. Treatment of spasticity.
    Marsden J, Stevenson V, Jarrett L.
    Handb Clin Neurol; 2023 Jul; 196():497-521. PubMed ID: 37620087
    [Abstract] [Full Text] [Related]

  • 4. [How to treat spasticity after stroke ?].
    Vogel L, Waxweiler C, Depierreux F.
    Rev Med Liege; 2022 Sep; 77(9):484-490. PubMed ID: 36082592
    [Abstract] [Full Text] [Related]

  • 5. Poststroke hypertonicity: upper limb assessment and treatment.
    Marciniak C.
    Top Stroke Rehabil; 2011 Sep; 18(3):179-94. PubMed ID: 21642056
    [Abstract] [Full Text] [Related]

  • 6. Spasticity and its contribution to hypertonia in cerebral palsy.
    Bar-On L, Molenaers G, Aertbeliën E, Van Campenhout A, Feys H, Nuttin B, Desloovere K.
    Biomed Res Int; 2015 Sep; 2015():317047. PubMed ID: 25649546
    [Abstract] [Full Text] [Related]

  • 7. Medical Updates in Management of Hypertonia.
    Dy R, Roge D.
    Phys Med Rehabil Clin N Am; 2020 Feb; 31(1):57-68. PubMed ID: 31760994
    [Abstract] [Full Text] [Related]

  • 8. Spasticity treatment with botulinum toxins.
    Ward AB.
    J Neural Transm (Vienna); 2008 Feb; 115(4):607-16. PubMed ID: 18389166
    [Abstract] [Full Text] [Related]

  • 9. Intrathecal baclofen in the management of post-stroke hypertonia: current applications and future directions.
    Francisco GE.
    Acta Neurochir Suppl; 2007 Feb; 97(Pt 1):219-26. PubMed ID: 17691380
    [Abstract] [Full Text] [Related]

  • 10.
    Kobeissy FH, Bose P, Hou J, Thompson FJ.
    ; 2015 Feb. PubMed ID: 26269896
    [Abstract] [Full Text] [Related]

  • 11. Management of spasticity in stroke.
    Bhakta BB.
    Br Med Bull; 2000 Feb; 56(2):476-85. PubMed ID: 11092096
    [Abstract] [Full Text] [Related]

  • 12. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R, Akturk S, Ersoy Y.
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
    [Abstract] [Full Text] [Related]

  • 13. [Selection of treatment modalities in patients with spasticity].
    Ota T.
    Brain Nerve; 2014 Sep; 66(9):1031-8. PubMed ID: 25200574
    [Abstract] [Full Text] [Related]

  • 14. Orally delivered baclofen to control spastic hypertonia in acquired brain injury.
    Meythaler JM, Clayton W, Davis LK, Guin-Renfroe S, Brunner RC.
    J Head Trauma Rehabil; 2004 Sep; 19(2):101-8. PubMed ID: 15247821
    [Abstract] [Full Text] [Related]

  • 15. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J, Entner T.
    Wien Klin Wochenschr; 2001 Sep; 113 Suppl 4():20-4. PubMed ID: 15506048
    [Abstract] [Full Text] [Related]

  • 16. The use of botulinum toxin in paediatric hypertonia.
    Fehlings D.
    Paediatr Child Health; 2005 Sep; 10(7):379-81. PubMed ID: 19668643
    [Abstract] [Full Text] [Related]

  • 17.
    Hui D, Argáez C.
    ; 2021 03. PubMed ID: 34260163
    [Abstract] [Full Text] [Related]

  • 18. Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.
    Sheean G.
    Drug Saf; 2006 03; 29(1):31-48. PubMed ID: 16454533
    [Abstract] [Full Text] [Related]

  • 19. Factors influencing goal attainment in patients with post-stroke upper limb spasticity following treatment with botulinum toxin A in real-life clinical practice: sub-analyses from the Upper Limb International Spasticity (ULIS)-II Study.
    Fheodoroff K, Ashford S, Jacinto J, Maisonobe P, Balcaitiene J, Turner-Stokes L.
    Toxins (Basel); 2015 Apr 08; 7(4):1192-205. PubMed ID: 25856546
    [Abstract] [Full Text] [Related]

  • 20. Pathophysiology of spasticity: implications for neurorehabilitation.
    Trompetto C, Marinelli L, Mori L, Pelosin E, Currà A, Molfetta L, Abbruzzese G.
    Biomed Res Int; 2014 Apr 08; 2014():354906. PubMed ID: 25530960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.